SUBJECTS : Adult Oncology | Amyloidosis | | Genetics | |
JACC. CardioOncology: 2023, vol: 5, issue: 3
- 1)- Peter A Henriksen, Stephen Rankin, Ninian N Lang. Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: Primer. JACC. CardioOncology. 2023, 5 (3): 292-297
Cited : 4Read More - 2)- Annet N Linders, Itamar B Dias, Ekaterina S Ovchinnikova, Mathilde C S C Vermeer, Martijn F Hoes, George Markousis Mavrogenis, Frederik E Deiman, Karla F Arevalo Gomez, Jacqueline M Bliley, Jamil Nehme, Aryan Vink, Jourik Gietema, Rudolf A de Boer, Daan Westenbrink, Herman H W Sillje, Denise Hilfiker-Kleiner, Linda W van Laake, Adam W Feinberg, Marco Demaria, Nils Bomer, Peter van der Meer. Evaluation of Senescence and Its Prevention in Doxorubicin-Induced Cardiotoxicity Using Dynamic Engineered Heart Tissues. JACC. CardioOncology. 2023, 5 (3): 298-315Cited : 3Read More
- 3)- Husam Abdel-Qadir, Rodrigo Carrasco, Peter C Austin, Yue Chen, Limei Zhou, Jiming Fang, Henry M H Su, Iliana C Lega, Padma Kaul, Tomas G Neilan, Paaladinesh Thavendiranathan. The Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Anthracycline-Treated Patients With Cancer. JACC. CardioOncology. 2023, 5 (3): 318-328Cited : 15Read More
- 4)- Safia Chatur, Edouard Fu, Muthiah Vaduganathan. Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology. JACC. CardioOncology. 2023, 5 (3): 329-331Cited : 1Read More
- 5)- Borja Ibáñez, Maria Gomes-Silva. Remote Ischemic Conditioning for Anthracycline Cardiotoxicity: The Need to Protect the Most Vulnerable. JACC. CardioOncology. 2023, 5 (3): 356-359Cited : 3Read More
- 6)- Peng Xia, Jingrui Chen, Yadav Sapkota, Erika N Scott, Yuening Liu, Melissa M Hudson, Shahrad R Rassekh, Bruce C Carleton, Colin J D Ross, Eric J Chow, Zhaokang Cheng. Regulates Cardiac Sensitivity to Anthracycline Chemotherapy. JACC. CardioOncology. 2023, 5 (3): 360-373Cited : 2Read More
- 7)- Rafael E Toro-Manotas, Sebastian D Santos-Patarroyo, Hector R Villarraga. Moving the Pendulum for Earlier Detection of Systolic and Diastolic Dysfunction in Cancer Survivors. JACC. CardioOncology. 2023, 5 (3): 389-391Cited : 1Read More
- 8)- Dimitrios Farmakis, Georgios Papingiotis, Gerasimos Filippatos. Genetic Predisposition to Cardiovascular Disease in Patients With Cancer: A Clinical Perspective. JACC. CardioOncology. 2023, 5 (3): 402-405Cited : 0Read More
- 9)- Jeannette R Wong-Siegel, Yuri Kim, Nathan O Stitziel, Ali Javaheri. Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet? JACC. CardioOncology. 2023, 5 (3): 406-408Cited : 1Read More
- 10)- Alexander R Lucas, Ralph D'Agostino, Jennifer H Jordan, Kerryn W Reding, Nathaniel S O'Connell, Giselle C Melendez, Fadi N Salloum, Kathryn E Weaver, Glenn J Lesser, W Gregory Hundley. Atorvastatin Does Not Attenuate Aortic Stiffening After Doxorubicin for Breast Cancer and Lymphoma (PREVENT-WF-98213). JACC. CardioOncology. 2023, 5 (3): 412-414Cited : 0Read More
